ABSTRACT We investigated the effects of disulfiram (DS) on ovarian carbonyl re ductase activity in rats to determine the influence of DS on female reproductive func tion. Three consecutive treatments with DS significantly inhibited ovarian carbonyl re ductase activity as well as ovulation, dose-dependently. Single treatment with DS had no effect on ovarian carbonyl reductase activity. Our observations indicate that con secutive treatment with DS has an inhibitory action on female reproductive function, although DS is well-known to inhibit aldehyde dehydrogenase and dopamine ,8-hy droxylase.
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We have already reported the properties and regulation of ovarian carbonyl reductase in rats (1 5). Carbonyl reductase (CR) (EC 1.1.1.184) in rat ovary is a soluble oxidoreduc tase that catalyzes an NADPH-dependent re duction of the carbonyl group of not only biologically active xenobiotics but also endog enous compounds such as prostaglandins (PGs) and steroids, reducing them to the correspond ing alcohols (1). Both the ovarian CR activity, which was measured using 13,14-dihydro-15 ketoprostaglandin Fla. (15KD-PGF2a) and 4 benzoylpyridine (4-BP) as substrates, and the ovarian CR content are linearly increased af ter the luteinizing hormone (LH) surge (2) . In immature rats, the ovarian CR activity and contents are significantly increased by human chorionic gonadotropin (hCG), and estradiol potentiates the stimulatory effect of hCG; furthermore, tamoxifen, an antiestrogen, antagonizes the action of estradiol on this en zyme (3, 4) . On the other hand, we have observed by immunohistochemical methods that the ovarian CR in rats is localized in the theca interna cells and the interstitial gland cells but not found in the granulosa cells (2 6) . These facts indicate that rat ovarian CR in androgen producing cells may be regulated by LH and estrogen and involved in ovarian func tions.
Disulfiram (DS) which inhibits aldehyde de hydrogenase (EC 1.2.1.3) in the liver has been used for over 30 years in avoidance therapy for patients with chronic alcoholism. In addi tion, DS is well-known to inhibit various drug metabolizing enzymes including dopamine /8 hydoxylase. Recently, Anderson et al. (7) have reported that gondotropin-induced pro lactin release is inhibited by pretreatment with DS in women with polycystic ovary syndrome and suggested that central dopaminergic tone was activated by the suppression of dopamine ,8-hydroxylase with DS. Furthermore, DS is reported to influence serotonin turnover in rat brain (8, 9) .
In the present study, we investigated the effects of DS on ovarian CR activity in rats in relation to ovulation.
MATERIALS AND METHODS

Animals
Mature Wistar-KY female rats (8 weeks old) were purchased from SLC (Shizuoka, Japan), and they were housed in group cages (4 or 5 rats per cage) under controlled conditions of light (12 hours on, 12 hours off) and tempera ture (23-25'C). Food and water were ad ministered ad libitum. Only animals that had shown at least two normal 4-day cycles, as de termined by daily vaginal smears before the start of the experiment, were used. Drug treatment DS was suspended in 0.5% carboxymethyl cellulose (CMC) solution. Rats were given DS (200 or 400 mg/kg) by consecutive or single oral administration and the concentration of DS was adjusted in the solution so that the final volume given was 2-3 ml. Control ani mals received an equal volume of vehicle (0.5% CMC solution).
Enzyme preparation
Rats were sacrificed on the second day of diestrus or on the day of estrus, and the ovar ies were immediately isolated and then homogenized in 6 ml of 10 mM phosphate buff er (pH 6.5) containing 0.154 M KC1, 1 mM dithiothreitol, 0.1 mM EDTA and 1 uM phenylmethylsulfonyl fluoride. The ovarian homogenate was centrifuged at 105000 X g for 60 min at 4°C, and the 105000 X g supernatant (cytosolic fraction) was obtained as a crude enzyme preparation. In the case of estrous rats, oviducts were examined for the presence of ova under a dissecting microscope.
Enzyme assay Ovarian CR activity was measured using 4-BP, 15KD-PGF2a, 4-nitroacetophenone (PNAP), menadione, 4-nitrobenzaldehyde (PNBA), 5a-androstanedione, and 5a-dihy drotestosterone (1, 2). The reductase activity was determined spectrophotometrically by measuring the oxidation rate of NADPH at 340 nm with a Hitachi 150-20 spectrophoto meter at 37°C. The standard assay mixture consisted of ovarian cytosol, substrate, 0.1 mM NADPH and 100 mM phosphate buffer (pH 6.5) in a total volume of 1.0 ml. One unit of the enzyme was defined as the amount that catalyzed the oxidation of 1,umole NADPH at 37°C. The reduction of 15KD-PGF2a was radiochemically determined by measuring 
Statistical analysis
All results were expressed as means ± S.E. Student's t-test was used for comparison be tween groups, with P values of 0.05 or less considered to indicate a significant difference.
RESULTS
Effects of three consecutive treatments with DS on tissue weight, ovulation and ovarian CR activity were investigated. DS (200 and 400 mg/kg) was orally administered for three days from the first day of diestrus, and the rats were sacrificed 24 hours after the final treatment with DS. Table I shows changes in the ovarian and uterine weights in relation to ovulation. Treatment with 400 mg/kg of DS resulted in a significant decrease in body weight and ovarian weight, and both 200 and 400 mg/kg of DS completely inhibited ovula tion. The ovarian CR activities towards va rious substrates after treatment with DS are summarized in Table 2 . The reductase activ ities towards 15KD-PGF2a, 4-BP, 5a-andro stanedione and 5 a -dihydrotestosterone were significantly decreased by 200 and 400 mg/kg of D S to 60 70% and 50 60% of the control values, respectively. In contrast, menadione reductase activity was increased 2-fold by con sective DS treatment (400 mg/kg). Consecu tive DS treatment had no effect on the reduc tion of either PNAP or PNBA in the ovarian cytosol of estrous rats.
To determine the effect of a single adminis tration of DS, a 400 mg/kg-dose of DS was given to diestrous or proestrous rats at 9 : 00 a.m., and then the ovaries were isolated 24 hours later. Table 3 shows changes in body weight, tissue weights, and ovarian CR activ ity. Body weight, ovarian and uterine weights did not change and ovulation was not in hibited by single treatment with DS to pro estrous rats. Ovarian CR activity was not appreciably affected by DS with the exception of PNBA reductase activity (Table 4) .
DISCUSSION
We have already demonstrated that both the activity and contents of ovarian CR are in creased by hCG and estrogen potentiated this stimulatory effect of hCG (1-6), and we also found that nonsteroidal antiestrogen and glu cocorticoids significantly decrease both the activity and contents of ovarian CR as well as inhibition of ovulation (13, 14) . These facts in dicate that the level of ovarian CR may be closely linked to ovarian function, especially the ovulatory process.
DS is well-known to inhibit dopamine 8 hydroxylase in brain tissue as well as aldehyde dehydrogenase (15) . On the other hand, dopa mine is established to inhibit prolactin release from the pituitary gland (16, 17) , and L-dopa treatment significantly decreased serum pro lactin (18) . Prolactin is reported to have a direct inhibitory effect on follicular estradiol production in rats (19) . These results suggest that dopamine increased by an inhibition of dopamine 8-hydroxylase with DS may influ ence release and production of pituitary pro lactin, gonadotropin, and ovarian estrogen.
Single treatment with DS had no effect on the parameters tested here. Fukumori et al. (8) has reported that single treatment with DS (200 mg/kg, i.p.) does not inhibit soluble aldehyde dehydrogenase and monoamine ox idase activity, but significantly decreases mitochondrial aldehyde dehydrogenase activity in rat brain. Thus, these results indicate that DS may not have an effect on the hypothalamo-pituitary ovaian axis by single treatment in this study.
We have found that DS strongly inhibits the activity of CR purified from rat ovary (1). Accordingly, it is thought that DS has inhibi tory effects on both dopamine 9-hydroxylase and ovarian CR. However, three consecutive treatments with DS caused not only a signifi cant decrease in CR activity, body weight, ovarian and uterine weights but also inhibition of ovulation. At present, we can not explain away the present results on three consecutive treatments with DS on the basis of dopamine elevation and prolactin decrease by the inhibi tion of dopamine ,8-hydroxylase. It appears that DS may inhibit gonadotropin, especially the LH surge before ovulation, and estrogen release. The ambiguity suggests that there may be other factors in the brain and the reproduc tive system which respond to DS. Neverthe less, it is obvious that long term treatment with DS decreases some ovarian and uterine functions. Rat ovarian CR catalyzed the re duction of PGE2 to PGF2a as well as the re duction of 15KD-PGF2,, to 13,14-H2-PGF2a (1). PGF2a is well-known to be a luteolytic factor and to have an action of uterine con traction. 13,14-H2-PGF2,., also possesses a luteolytic action in heifer (20) and stimulated steroidogenesis in vitro (21) . The present re sults that DS inhibited directly or indirectly ovarian CR activity mean the decrement of re productive function in female rats. Carbonyl reductase as well as aldehyde re ductase (EC 1.1.1.2) and aldose reductase (EC 1.1.1.21) belong to the aldo/keto reductase family (22) . In this study, the effect of DS on PNBA reductase activity was different from other reductase activities tested. Recently, we have purified aldose reductase from rat ovary and demonstrated that ovarian aldose reduc tase shows higher affinity for PNBA than ova rian CR (23) . Thus, PNBA reductase activity in rat ovary may depend on aldose reductase and aldehyde reductase rather than CR. As shown in this study, the regulation of these re ductases may be also different from ovarian CR. On the other hand, only menadione re ductase activity was increased by consecutive treatment of DS. A possible explanation for this observation is that DT-diaphorase (EC 1.6.99.2) in rat ovary is induced by DS. In fact, this activity was inhibited by dicoumarol, a potent inhibitor of DT-diaphorase (24) (data not shown). However, the physiological role of DT-diaphorase in the ovary is still un known.
Further investigations to determine the mode of action of DS on ovarian CR and re productive system are in progress.
